pirfenidone has been researched along with Postoperative Complications in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Aokage, K; Ishii, G; Miyoshi, T; Sekihara, K; Tane, K; Tsuboi, M | 1 |
| Bargagli, E; Bennett, D; De Vita, E; Fossi, A; Lanzarone, N; Luzzi, L; Paladini, P; Perillo, F; Rottoli, P; Sestini, P | 1 |
| Maeda, S | 1 |
| Arízaga Maguregui, A; González Larrocha, O; Ortega Mera, U; Romero Rojano, P | 1 |
| Dupont, LJ; Gheysens, O; Godinas, L; Goffin, KE; Heigl, T; McDonough, JE; Neyrinck, AP; Sacreas, A; Schaevers, V; Van Herck, A; Van Raemdonck, DE; Vanaudenaerde, BM; Verbeken, EK; Verleden, GM; Verleden, SE; Vos, R; Wuyts, WA; Yserbyt, J | 1 |
| De Jong, PA; De Raedt, N; Dupont, LJ; Gheysens, O; Ruttens, D; Van Raemdonck, DE; Vanaudenaerde, BM; Vandermeulen, E; Verleden, GM; Verleden, SE; Vos, R; Yserbyt, J | 1 |
| Iwata, T; Mizobuchi, T; Nagato, K; Nakajima, T; Nakatani, Y; Ota, S; Suzuki, H; Tagawa, T; Yoshida, S; Yoshino, I | 1 |
| Kunii, E; Moriyama, S; Niimi, A; Ohkubo, H | 1 |
| Akcılar, A; Akcılar, R; Bayhan, Z; Kargı, E; Kocak, C; Kocak, FE; Tiryaki, C; Yaylak, F; Zeren, S | 1 |
| Fujiwara, T; Iwata, T; Nakajima, T; Suzuki, H; Wada, H; Yoshida, S; Yoshino, I | 1 |
| Calik, E; Guvenal, T; Hasdemir, PS; Koltan, SO; Koyuncu, FM; Ozbilgin, K; Ozkut, M; Uner, MA | 1 |
| Delanote, I; Verbeken, EK; Verleden, GM; Vos, R; Wuyts, WA; Yserbyt, J | 1 |
| Araki, K; Hirai, K; Hoshino, K; Igarashi, T; Ishii, N; Kubo, N; Kuwano, H; Saitoh, F; Shirabe, K; Tsukagoshi, M; Watanabe, A; Yamanaka, T | 1 |
| Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H | 1 |
| Choi, JS; Jung, KI; Kim, HK; Shin, SY | 1 |
| Margolin, SB; Metcalfe, MS; Nicholson, ML; Toomey, D; Waller, JR | 1 |
| Fernandez, F; Jendrisak, M; Margolin, SB; Marshbank, S; McKane, BW; Mohanakumar, T; Narayanan, K | 1 |
| Dosanjh, A | 1 |
3 review(s) available for pirfenidone and Postoperative Complications
| Article | Year |
|---|---|
[Perioperative Management of Patients with Pulmonary Comorbidities Undergoing Lung Resection].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Comorbidity; Glucocorticoids; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Methylprednisolone; Perioperative Care; Pneumonectomy; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pyridones; Respiratory Insufficiency | 2017 |
Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review.
Topics: Aged; Biomarkers; Carcinoma, Hepatocellular; Disease Progression; Hepatectomy; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Male; Mucin-1; Perioperative Care; Postoperative Complications; Pyridones; Respiration Disorders; Tomography, X-Ray Computed | 2017 |
Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bronchiolitis Obliterans; Humans; Lung Transplantation; Postoperative Complications; Pyridones; Transplantation, Homologous | 2006 |
15 other study(ies) available for pirfenidone and Postoperative Complications
| Article | Year |
|---|---|
Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Middle Aged; Negative Results; Patient Selection; Perioperative Care; Postoperative Complications; Prognosis; Pyridones; Survival Rate | 2020 |
Pirfenidone in chronic lung allograft dysfunction: a single cohort study.
Topics: Aged; Chronic Disease; Female; Forced Expiratory Volume; Humans; Lung; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pyridones; Recovery of Function; Retrospective Studies; Time Factors; Treatment Outcome | 2020 |
Recommendations for perioperative management of new pharmacological antifibrotic therapy in idiopathic pulmonary fibrosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; Fibroblasts; Hemodynamics; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Intraoperative Complications; Multicenter Studies as Topic; Perioperative Care; Postoperative Complications; Preanesthetic Medication; Pyridones; Vital Capacity | 2018 |
Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.
Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Primary Graft Dysfunction; Prognosis; Pulmonary Fibrosis; Pyridones; Retrospective Studies; Risk Factors; Syndrome | 2018 |
Pirfenidone: a potential new therapy for restrictive allograft syndrome?
Topics: Allografts; Anti-Inflammatory Agents, Non-Steroidal; Emphysema; Fluorodeoxyglucose F18; Humans; Lung Transplantation; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Pulmonary Fibrosis; Pyridones; Radiopharmaceuticals; Syndrome; Tumor Necrosis Factor-alpha | 2013 |
Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Disease Progression; Feasibility Studies; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Middle Aged; Perioperative Care; Postoperative Complications; Pyridones; Retrospective Studies; Treatment Outcome | 2015 |
Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
Topics: Acute-Phase Reaction; Aged, 80 and over; Disease Progression; Drug Therapy, Combination; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Infusions, Intravenous; Lung Neoplasms; Male; Methylprednisolone; Postoperative Complications; Prednisolone; Pulse Therapy, Drug; Pyridones; Treatment Outcome | 2015 |
Antiadhesive and anti-inflammatory effects of pirfenidone in postoperative intra-abdominal adhesion in an experimental rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Male; Matrix Metalloproteinase 9; Peritoneum; Postoperative Complications; Pyridones; Random Allocation; Rats, Sprague-Dawley; Tissue Adhesions; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2016 |
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idiopathic Pulmonary Fibrosis; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Perioperative Care; Pneumonectomy; Postoperative Complications; Pyridones; Retrospective Studies; Risk Assessment; Risk Factors; Smoking | 2016 |
Effect of Pirfenidone on Vascular Proliferation, Inflammation and Fibrosis in an Abdominal Adhesion Rat Model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Female; Inflammation; Injections, Intraperitoneal; Interleukin-17; Neovascularization, Pathologic; Peritoneum; Postoperative Complications; Pyridones; Rats; Rats, Wistar; Tissue Adhesions; Transforming Growth Factor beta; Treatment Outcome; Uterus | 2017 |
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Belgium; Disease Progression; Female; Graft Survival; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pyridones; Retrospective Studies; Tertiary Care Centers; Vital Capacity | 2016 |
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
Topics: Actins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Cell Proliferation; Cicatrix; Collagen; Conjunctival Diseases; Disease Models, Animal; Drug Evaluation; Endothelium, Corneal; Glaucoma; Intraocular Pressure; Mitomycin; Ophthalmic Solutions; Postoperative Complications; Proliferating Cell Nuclear Antigen; Pyridones; Rabbits; Trabeculectomy; Tumor Necrosis Factor-alpha | 2011 |
Effects of an anti-transforming growth factor-β agent (pirfenidone) on strabismus surgery in rabbits.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Follow-Up Studies; Inflammation; Oculomotor Muscles; Postoperative Complications; Pyridones; Rabbits; Strabismus; Transforming Growth Factor beta; Wound Healing | 2012 |
Pirfenidone inhibits early neointimal proliferation following arterial injury.
Topics: Animal Feed; Animals; Cell Division; Dietary Supplements; Hyperplasia; Male; Muscle, Smooth, Vascular; Postoperative Complications; Pyridones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tunica Intima; Vascular Diseases | 2002 |
Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchiolitis Obliterans; Chronic Disease; Disease Models, Animal; Graft Rejection; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Postoperative Complications; Pyridones; Trachea; Transplantation, Homologous | 2004 |